151
|
De Hooge M, Pialat J, Feydy A, Reijnierse M, Claudepierre P, Saraux A, Dougados M, van der Heijde D. FRI0244 Prevalence of MRI Spinal Lesions Typical for Axial Spondyloarthritis in Patients with Inflammatory Back Pain. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
152
|
Navarro-Compán V, Gherghe A, Smolen J, Aletaha D, Landewé R, van der Heijde D. AB0298 Relation between Disease Activity Indices and their Individual Components and Radiographic Progression in Rheumatoid Arthritis: A Systematic Literature Review. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1640] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
153
|
Siebuhr A, Ramiro S, Bay-Jensen AC, van der Heijde D, Landewé R, Tubergen A, Karsdag M. SAT0332 Connective Tissue Degradation by Matrix Metalloproteinases (C1M) is Predictive of Radiographic Progression in Ankylosing Spondylitis Preferentially in Patients Who Smoke: Table 1. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.5191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
154
|
De Bruin F, Treyvaud M, Feydy A, Bloem J, Dougados M, Gossec L, van der Heijde D, Reijnierse M. OP0162 Degenerative Changes of the Spine on MRI in Patients with Inflammatory Back Pain from the DESIR Cohort:. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
155
|
Mease P, Fleischmann R, Davies O, Nurminen T, van der Heijde D. SAT0405 Disease Activity and Clinical Response Early in the Course of Treatment PREDICT Long-Term Outcomes in Psoriatic Arthritis Patients Treated with Certolizumab Pegol. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
156
|
Mease P, Fleischmann R, Wollenhaupt J, Deodhar A, Gladman D, Hoepken B, Peterson L, van der Heijde D. OP0077 Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Psoriatic Arthritis with and without Prior Anti-Tumor Necrosis Factor Exposure: 96-Week Outcomes from the Rapid-Psa Trial. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1652] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
157
|
van der Heijde D, Joshi A, Mittal M, Pangan A, Chen N, Betts K, Qi C, Bao Y. SAT0339 Asas40 and ASDAS Responses Are Associated with Improved Physical Function, Hrqol, and Work Productivity in Patients with Non-Radiographic Axial Spondyloarthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
158
|
Machado P, Navarro-Compán V, Landewé R, van der Heijde D. FRI0126 The Ankylosing Spondylitis Disease Activity Score (ASDAS): Defining the Best Calculation Method When the Conventional C-Reactive Protein (CRP) is below the Threshold of Detection - Results from the DESIR Cohort. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
159
|
Essers I, Ramiro S, Stolwijk C, Blaauw M, Landewé R, van der Heijde D, van den Bosch F, Dougados M, van Tubergen A. FRI0117 Disease Activity is Associated with Development of Inflammatory Bowel Disease in Ankylosing Spondylitis: 12-Year Results from Oasis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1857] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
160
|
Ramiro S, van Tubergen A, van der Heijde D, Stolwijk C, Dougados M, van den Bosch F, Landewé R. THU0102 Higher Disease Activity Leads to More Damage in the Early Phases of Ankylosing Spondylitis: 12-Year Data from the OASIS Cohort: Table 1. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
161
|
van den Berg R, Lenczner G, Thévenin F, Claudepierre P, Feydy A, Reijnierse M, Saraux A, Rahmouni A, Dougados M, van der Heijde D. OP0160 Classification of Axspa Based on Positive Imaging (Radiographs and/or MRI of the Sacroiliac Joints) by Local Rheumatologists or Radiologists versus Central Trained Readers in the Desir-Cohort. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
162
|
Aga AB, Hammer H, Olsen I, Uhlig T, van der Heijde D, Kvien T, Haavardsholm E. SAT0172 Prevalence of Ultrasonographic Joint Inflammation in Rheumatoid Arthritis (RA): A Comparative Study of 230 Early and 212 Established RA Patients Starting DMARD Treatment. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
163
|
Essers I, Ramiro S, Stolwijk C, Blaauw M, Landewé R, van der Heijde D, van den Bosch F, Dougados M, van Tubergen A. AB0699 Contribution of Extra-Articular Manifestations to the Burden of Disease in Ankylosing Spondylitis. A Longitudinal Study. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1873] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
164
|
van den Berg R, Thévenin F, Feydy A, Claudepierre P, Reijnierse M, Saraux A, Rahmouni A, Dougados M, van der Heijde D. AB1009 Concordance between “A Positive MRI of the Sacroiliac Joints” Based on the Local Reading versus A Centralised Reading: Experience from the Desir-Cohort. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.3510] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
165
|
Pellegrom S, de Hooge M, Huizinga T, van der Heijde D, van Gaalen F. AB0720 Performance of Referral Parameters of Patients with Chronic Back Pain Included in the Spondyloarthritis Caught Early Cohort (SPACE): Table 1. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.3367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
166
|
de Hooge M, Claudepierre P, Feydy A, Reijnierse M, Saraux A, Dougados M, van der Heijde D. FRI0245 How Reliable is the Scoring of Msasss in Clinical Practice in Centers Participating in Desir? Comparison with the Gold Standard Central Reading: Table 1. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1522] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
167
|
Rudwaleit M, Landewé R, Marzo-Ortega H, Sieper J, van der Heijde D, Rosenbaum J, Davies O, Stach C, Nurminen T, Deodhar A. SAT0355 Observed Incidence Rates of Uveitis following Certolizumab Pegol Treatment in Patients with Axial Spondyloarthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1806] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
168
|
van Onna M, van Tubergen A, van der Heijde D, Jurik AG, Landewé R. Gadolinium contrast-enhanced MRI sequence does not have an incremental value in the assessment of sacroiliitis in patients with early inflammatory back pain by using MRI in combination with pelvic radiographs: a 2-year follow-up study. Clin Exp Rheumatol 2014; 32:225-230. [PMID: 24428976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2013] [Accepted: 11/12/2013] [Indexed: 06/03/2023]
Abstract
OBJECTIVES To evaluate the potential incremental value in detecting sacroiliitis of the T1 post-gadolinium diethylenetriaminepenta-acetic acid (Gd-DTPA) MRI sequence of the sacroiliac joints (SIJ) compared with the combination of short tau inversion recovery (STIR) MRI sequence and pelvic radiographs in patients with inflammatory back pain (IBP) suspected for axial spondyloarthritis. METHODS A 2-year follow-up study was conducted in patients with IBP of less than 2 years duration. Annual MRI of the SIJ (MRI-SIJ) was performed and scored for bone marrow oedema (BME). Pelvic radiographs were scored according to the modified New York (mNY) criteria. Agreement on the presence of BME detected by the STIR and post-Gd-DTPA sequence and the incremental value of post-Gd-DTPA sequence over STIR plus radiographs was analysed by descriptive methods and kappa statistics. RESULTS At baseline, 20 (29%) out of 68 patients (38% male; mean (SD) age 34.9 (10.3) years) enrolled had BME both on the STIR and post-Gd-DTPA sequences; 4 patients (6%) on the STIR sequence only; none on the post-Gd-DTPA sequence only (kappa value: 0.87). Fifteen (22%) patients fulfilled the mNY criteria at baseline. Sixty-two (91%) patients had at least 1 follow-up MRI-SIJ. At 2-year follow-up, 2 patients had BME on the post-Gd-DTPA sequence without BME on the STIR sequence. These 2 patients already fulfilled the mNY criteria at baseline. CONCLUSIONS In this cohort of patients with early IBP, the post-Gd-DTPA sequence of the MRI-SIJ did not have an incremental value in the detection of sacroiliitis compared with the STIR sequence plus pelvic radiographs.
Collapse
Affiliation(s)
- M van Onna
- Department of Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.
| | | | | | | | | |
Collapse
|
169
|
Keystone E, van der Heijde D, Weinblatt M, Kavanaugh A, Kupper H, Liu S, Mozaffarian N. SAT0127 Effective disease control following up to 10 years of treatment with adalimumab in patients with long-standing rheumatoid arthritis and an inadequate response to methotrexate: final 10-year results of the DE019 trial. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2012-eular.3074] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
170
|
Schiff M, Fleischmann R, Weinblatt M, Valente R, van der Heijde D, Citera G, Zhao C, Maldonado M. OP0022 Abatacept sc versus adalimumab on background methotrexate in RA: One year results from the ample study. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2012-eular.1705] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
171
|
Weinblatt M, Fleischmann R, Davies O, Luijtens K, van der Heijde D. SAT0145 Timing and magnitude of initial response to certolizumab pegol in a broad population of patients with active rheumatoid arthritis predicts likelihood of LDA at week 28:. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2012-eular.3092] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
172
|
Machado P, Landewé R, Braun J, Baraliakos X, Hermann KG, Hsu B, Baker D, van der Heijde D. FRI0291 MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a TNF inhibitor:. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2012-eular.2748] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
173
|
Dougados M, van der Heijde D, Sieper J, Braun J, Maksymowych WP, Citera G, Pedersen R, Bonin R, Bukowski J, Koenig AS, Vlahos B, Alvarez D. OP0108 Clinical and Imaging Efficacy of Etanercept in Early Non-Radiographic Axial Spondyloarthritis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.313] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
174
|
van der Heijde D, Deodhar A, Braun J, Mack M, Hsu B, Gathany T, Han C, Inman R. OP0170 Achieving ASDAS-CRP major improvement and inactive disease in patients with ankylosing spondylitis after treatment with golimumab is associated with normalized health related quality of life: Two-year results from the go-raise trial. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2012-eular.1853] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
175
|
Kavanaugh A, Mease PJ, Purcaru O, van der Heijde D. SAT0275 High Economic Burden of Moderate to Severe Psoriatic Arthritis on Paid Work and Household Productivity: Baseline Results from the Rapid-Psa Study. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.2000] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
176
|
Keystone E, Landewé R, van Vollenhoven R, Combe B, Strand V, Mease PJ, Shaughnessy L, VanLunen B, van der Heijde D. THU0192 5-Year Results from the Rapid 1 Trial and Open-Label Extension: Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.720] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
177
|
Dougados M, Devauchelle-Pensec V, Ferlet JF, Jousse-Joulin S, D’Agostino MA, Backhaus M, Bentin J, Chalès G, Chary-Valckenaere I, Conaghan P, Etchepare F, Gaudin P, Grassi W, van der Heijde D, Mariette X, Naredo E, Szkudlarek M, Wakefield R, Saraux A. SAT0408 Both clinical and ultrasonographic evaluation of synovitis are relevant to predict subsequent radiological deterioration in rheumatoid arthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2012-eular.3354] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
178
|
Sieper J, van der Heijde D, Dougados M, van den Bosch F, Goupille P, Sarkar S, Pangan A. THU0275 Sustained efficacy of adalimumab in patients with non-radiographic axial spondyloarthritis: Week 68 results from ability 1:. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2012-eular.2240] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
179
|
Landewé R, Rudwaleit M, van der Heijde D, Dougados M, Maksymowych WP, Braun J, Deodhar A, Stach C, Hoepken B, Coteur G, Kielar D, Fichtner A, Arledge T, Sieper J. OP0106 Effect of Certolizumab Pegol on Signs and Symptoms of Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 24-Week Results of Rapid-Axspa Study. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.311] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
180
|
van den Berg R, de Hooge M, Navarro Compán V, Reijnierse M, van Gaalen F, Fagerli K, Turina M, van Oosterhout M, Punzi L, Huizinga T, van der Heijde D. OP0271 Prevalence of Structural Lesions on MRI of the Sacroiliac Joints in Patients with Early Axial Spondyloarthritis and Patients with Back Pain. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.476] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
181
|
Deodhar A, Braun J, Inman R, van der Heijde D, Zhou Y, Hsu B. THU0352 Long-Term Safety and Efficacy of Golimumab in the Treatment of Ankylosing Spondylitis: Results Through 5 Years of the Go-Raise Trial. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.880] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
182
|
Keystone EC, Breedveld FC, van der Heijde D, Landewé R, Florentinus S, Arulmani U, Liu S, Kupper H, Kavanaugh A. THU0190 Long-Term Impact of Delaying Combination Therapy with Adalimumab Plus Methotrexate by 2 Years in Patients with Early Rheumatoid Arthritis: Final 10-Year Results of the Premier Trial. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.718] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
183
|
Mease PJ, Fleischmann R, Wollenhaupt J, Deodar A, Kielar D, Woltering F, Stach C, Hoepken B, Arledge T, van der Heijde D. SAT0298 Effect of Certolizumab Pegol on Signs and Symptoms in Patients with Psoriatic Arthritis from the Rapid-PSA Study: Impact of Baseline Skin Involvement and Prior Anti-TNF Therapy. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.2023] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
184
|
Smolen JS, Braun J, Dougados M, Emery P, FitzGerald O, Helliwell P, Kavanaugh A, Kvien TK, Landewé R, Luger T, Mease P, Olivieri I, Reveille J, Ritchlin C, Rudwaleit M, Schoels M, Sieper J, de Wit M, van der Heijde D. OP0110 Treat-To-Target Recommendations for Spondyloarthritis, Including Ankylosing Spondylitis and Psoriatic Arthritis: A Consensus of an International Task Force. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.315] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
185
|
van der Heijde D, Sieper J, Maksymowych W, Brown M, Sarkar S, Pangan A. FRI0270 Concurrent sacroiliac joint and spinal inflammation on MRI in patients with non-radiographic axial spondyloarthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2012-eular.2727] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
186
|
Fagerli KM, van der Heijde D, Heiberg MS, Wierød A, Rødevand E, Mikkelsen K, Kalstad S, Kvien TK, Lie E. FRI0411 Response and drug survival of sulfasalazine in an observational study (nor-dmard) of dmard-naïve patients with axial spondyloarthritis (SPA). Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.1538] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
187
|
Braun J, van der Heijde D, Hermann KG, Baraliakos X, Deodhar A, Beutler A, Mack M, Xu W, Hsu B, Inman R. THU0278 The effect of anti-tumor necrosis factor therapy with golimumab on radiographic progression in definite ankylosing spondylitis: 4-year results:. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2012-eular.2243] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
188
|
van der Heijde D, Maksymowych W, Sieper J, Lambert R, Brown MA, Rathmann S, Anderson J, Pangan AL. THU0361 Relationship between MRI and Clinical Remission in Patients with Non-Radiographic Axial Spondyloarthritis after Two Years of Adalimumab Therapy. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.889] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
189
|
de Hooge M, van den Berg R, van Gaalen F, Reijnierse M, Huizinga T, van der Heijde D. SAT0275 Almost 40% of patients with chronic back pain starting before the age of 45 fulfill the asas axial spondyloarthritis criteria:. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2012-eular.3222] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
190
|
Aga AB, Lie E, Uhlig T, Hammer HB, van der Heijde D, Kvien TK, Haavardsholm EA. THU0506 In an Inception Cohort of 175 DMARD NaÏve Ra Patients Classified According to the 2010 ACR/EULAR Criteria a Large Proportion of Patients does not Fulfill the 1987 ACR Criteria. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.1034] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
191
|
Mease P, Fleischmann R, Deodhar A, Wollenhaupt J, Kielar D, Woltering F, Stach C, Hoepken B, Arledge T, van der Heijde D. LB0001 Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24 week results of a phase 3 double blind randomized placebo-controlled study (rapid-PSA). Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2012-eular.1961] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
192
|
van der Heijde D, Maksymowych WP, Landewé R, Stach C, Hoepken B, Fichtner A, Kielar D, Braun J. FRI0419 Effect of certolizumab pegol on inflammation of spine and sacroiliac joints in patients with axial spondyloarthritis: 12-week magnetic resonance imaging results of rapid-axspa study. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.1546] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
193
|
Ramiro S, Stolwijk C, van Tubergen A, van der Heijde D, Dougados M, van den Bosch F, Landewé R. SAT0248 Evolution of Radiographic Damage in Ankylosing Spondylitis Over 12 Years of Follow-Up. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.1973] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
194
|
Kiltz U, van der Heijde D, Boonen A, Cieza A, Stucki G, Khan MA, Maksymowych WP, Marzo-Ortega H, Reveille J, Stebbings S, Bostan C, Braun J. Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS. Ann Rheum Dis 2014; 74:830-5. [PMID: 24399232 DOI: 10.1136/annrheumdis-2013-203967] [Citation(s) in RCA: 125] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2013] [Accepted: 12/10/2013] [Indexed: 11/03/2022]
Abstract
OBJECTIVES The burden of disease in patients with ankylosing spondylitis (AS) can be considerable. However, no agreement has been reached among expert members of Assessment of SpondyloArthritis International Society (ASAS) to define severity of AS. Based on the International Classification of Functioning, Disability and Health (ICF), a core set of items for AS has been selected to represent the entire spectrum of possible problems in functioning. Based on this, the objective of this study was to develop a tool to quantify health in AS, the ASAS Health Index. METHODS First, based on a literature search, experts' and patients' opinion, a large item pool covering the categories of the ICF core set was generated. In several steps this item pool was reduced based on reliability, Rasch analysis and consensus building after two cross-sectional surveys to come up with the best fitting items representing most categories of the ICF core set for AS. RESULTS After the first survey with 1754 patients, the item pool of 251 items was reduced to 82. After selection by an expert committee, 50 items remained which were tested in a second cross-sectional survey. The results were used to reduce the number of items to a final set of 17 items. This selection showed the best reliability and fit to the Rasch model, no residual correlation, and absence of consistent differential item function and a Person Separation Index of 0.82. CONCLUSIONS In this long sequential study, 17 items which cover most of the ICF core set were identified that showed the best representation of the health status of patients with AS. The ASAS Health Index is a linear composite measure which differs from other measures in the public domain.
Collapse
Affiliation(s)
- U Kiltz
- Rheumazentrum Ruhrgebiet, Herne, Germany
| | - D van der Heijde
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
| | - A Boonen
- Division of Rheumatology, Department of Internal Medicine, Maastricht University Medical Center, and Caphri Research Institute, Maastricht, The Netherlands
| | - A Cieza
- eFaculty of Social and Human Sciences, Schools of Psychology, University of Southampton, Southampton, UK
| | - G Stucki
- Department of Health Sciences and Health Policy, University of Lucerne, Lucerne, Switzerland Swiss Paraplegic Research, Nottwil, Switzerland ICF Research Branch in cooperation with the WHO Family of International Classifications Collaborating Centre in Germany (at DIMDI), Munich, Germany
| | - M A Khan
- Case Western Reserve University, Cleveland, Ohio, USA
| | - W P Maksymowych
- Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
| | - H Marzo-Ortega
- Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK
| | - J Reveille
- Division of Rheumatology and Clinical Immunogenetics, Department of Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA
| | - S Stebbings
- Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand
| | - C Bostan
- Swiss Paraplegic Research, Nottwil, Switzerland ICF Research Branch in cooperation with the WHO Family of International Classifications Collaborating Centre in Germany (at DIMDI), Munich, Germany
| | - J Braun
- Rheumazentrum Ruhrgebiet, Herne, Germany
| |
Collapse
|
195
|
Schoels MM, Braun J, Dougados M, Emery P, Fitzgerald O, Kavanaugh A, Kvien TK, Landewé R, Luger T, Mease P, Olivieri I, Reveille J, Ritchlin C, Rudwaleit M, Sieper J, Smolen JS, Wit MD, van der Heijde D. Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis. Ann Rheum Dis 2014; 73:238-42. [PMID: 23740234 PMCID: PMC3888585 DOI: 10.1136/annrheumdis-2013-203860] [Citation(s) in RCA: 58] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/15/2013] [Indexed: 12/31/2022]
Abstract
BACKGROUND Current recommendations for the management of axial spondyloarthritis (SpA) and psoriatic arthritis are to monitor disease activity and adjust therapy accordingly. However, treatment targets and timeframes of change have not been defined. An international expert panel has been convened to develop 'treat-to-target' recommendations, based on published evidence and expert opinion. OBJECTIVE To review evidence on targeted treatment for axial and peripheral SpA, as well as for psoriatic skin disease. METHODS We performed a systematic literature search covering Medline, Embase and Cochrane, conference abstracts and studies in http://www.clinicaltrials.gov. RESULTS Randomised comparisons of targeted versus routine treatment are lacking. Some studies implemented treatment targets before escalating therapy: in ankylosing spondylitis, most trials used a decrease in Bath Ankylosing Spondylitis Disease Activity Index; in psoriatic arthritis, protocols primarily considered a reduction in swollen and tender joints; in psoriasis, the Modified Psoriasis Severity Score and the Psoriasis Area and Severity Index were used. Complementary evidence correlating these factors with function and radiographic damage at follow-up is sparse and equivocal. CONCLUSIONS There is a need for randomised trials that investigate the value of treat-to-target recommendations in SpA and psoriasis. Several trials have used thresholds of disease activity measures to guide treatment decisions. However, evidence on the effect of these data on long-term outcome is scarce. The search data informed the expert committee regarding the formulation of recommendations and a research agenda.
Collapse
Affiliation(s)
- M M Schoels
- 2nd Department of Internal Medicine, Center for Rheumatic Diseases, Hietzing Hospital, , Vienna, Austria
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
196
|
Mease PJ, Fleischmann R, Deodhar AA, Wollenhaupt J, Khraishi M, Kielar D, Woltering F, Stach C, Hoepken B, Arledge T, van der Heijde D. Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA). Ann Rheum Dis 2014; 73:48-55. [PMID: 23942868 PMCID: PMC3888622 DOI: 10.1136/annrheumdis-2013-203696] [Citation(s) in RCA: 323] [Impact Index Per Article: 32.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2013] [Revised: 06/12/2013] [Accepted: 06/26/2013] [Indexed: 11/03/2022]
Abstract
OBJECTIVES To evaluate the efficacy and safety of certolizumab pegol (CZP) after 24 weeks in RAPID-PsA (NCT01087788), an ongoing Phase 3 trial in patients with psoriatic arthritis (PsA). METHODS Patients were randomised 1:1:1 to placebo, 200 mg CZP every 2 weeks (Q2W) or 400 mg CZP every 4 weeks (Q4W). Patients could have had exposure to one previous tumour necrosis factor (TNF) inhibitor therapy. Primary endpoints were American College of Rheumatology 20% (ACR20) response at week 12 and modified Total Sharp Score change from baseline at week 24. Secondary endpoints included; Psoriatic Arthritis Response Criteria (PsARC) score, Health Assessment Questionnaire Disability Index (HAQ-DI), Psoriasis Area and Severity Index, Leeds Enthesitis Index, Leeds Dactylitis Index, and Modified Nail Psoriasis Severity Index. RESULTS Of 409 patients randomised, 368 completed 24 weeks of treatment. ACR20 response was significantly greater in CZP 200 mg Q2W and 400 mg Q4W-treated patients than placebo (58.0% and 51.9% vs 24.3% (p<0.001)) at week 12, with improvements observed by week 1. There was a statistically significant improvement in physical function from baseline, measured by HAQ-DI in CZP patients compared with placebo (-0.50 vs -0.19, p<0.001) and more patients treated with CZP 200 mg Q2W and CZP 400 mg achieved an improvement in PsARC at week 24 than placebo (78.3% and 77.0% vs 33.1% (p<0.001)). Sustained improvements were observed in psoriatic skin involvement, enthesitis, dactylitis and nail disease. Higher ACR20 response with CZP was independent of prior TNF inhibitor exposure. No new safety signals were observed. CONCLUSIONS Rapid improvements in the signs and symptoms of PsA, including joints, skin, enthesitis, dactylitis and nail disease were observed across both CZP dosing regimens.
Collapse
Affiliation(s)
- P J Mease
- Swedish Medical Center and University of Washington, , Seattle, Washington, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
197
|
Landewé R, Braun J, Deodhar A, Dougados M, Maksymowych WP, Mease PJ, Reveille JD, Rudwaleit M, van der Heijde D, Stach C, Hoepken B, Fichtner A, Coteur G, de Longueville M, Sieper J. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study. Ann Rheum Dis 2014; 73:39-47. [PMID: 24013647 PMCID: PMC3888598 DOI: 10.1136/annrheumdis-2013-204231] [Citation(s) in RCA: 322] [Impact Index Per Article: 32.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2013] [Revised: 08/19/2013] [Accepted: 08/20/2013] [Indexed: 12/14/2022]
Abstract
OBJECTIVES To evaluate the efficacy and safety of certolizumab pegol (CZP) after 24 weeks in RAPID-axSpA (NCT01087762), an ongoing Phase 3 trial in patients with axial spondyloarthritis (axSpA), including patients with ankylosing spondylitis (AS) and non-radiographic axSpA (nr-axSpA). METHODS Patients with active axSpA were randomised 1:1:1 to placebo, CZP 200 mg every 2 weeks (Q2W) or CZP 400 mg every 4 weeks (Q4W). In total 325 patients were randomised. Primary endpoint was ASAS20 (Assessment of SpondyloArthritis international Society 20) response at week 12. Secondary outcomes included change from baseline in Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and Bath Ankylosing Spondylitis Metrology Index (BASMI) linear. RESULTS Baseline disease activity was similar between AS and nr-axSpA. At week 12, ASAS20 response rates were significantly higher in CZP 200 mg Q2W and CZP 400 mg Q4W arms versus placebo (57.7 and 63.6 vs 38.3, p≤0.004). At week 24, combined CZP arms showed significant (p<0.001) differences in change from baseline versus placebo in BASFI (-2.28 vs -0.40), BASDAI (-3.05 vs -1.05), and BASMI (-0.52 vs -0.07). Improvements were observed as early as week 1. Similar improvements were reported with CZP versus placebo in both AS and nr-axSpA subpopulations. Adverse events were reported in 70.4% vs 62.6%, and serious adverse events in 4.7% vs 4.7% of All CZP versus placebo groups. No deaths or malignancies were reported. CONCLUSIONS CZP rapidly reduced the signs and symptoms of axSpA, with no new safety signals observed compared to the safety profile of CZP in RA. Similar improvements were observed across CZP dosing regimens, and in AS and nr-axSpA patients.
Collapse
Affiliation(s)
- R Landewé
- Academic Medical Center Amsterdam & Atrium Medical Center Heerlen, , Amsterdam, The Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
198
|
Krabben A, Stomp W, Huizinga TWJ, van der Heijde D, Bloem JL, Reijnierse M, van der Helm-van Mil AHM. Concordance between inflammation at physical examination and on MRI in patients with early arthritis. Ann Rheum Dis 2013; 74:506-12. [PMID: 24336009 DOI: 10.1136/annrheumdis-2013-204005] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND MRI is increasingly used to measure inflammation in rheumatoid arthritis (RA) research, but the correlation to clinical assessment is unexplored. This study determined the association and concordance between inflammation of small joints measured with MRI and physical examination. METHODS 179 patients with early arthritis underwent a 68 tender joint count and 66 swollen joint count and 1.5T MRI of MCP (2-5), wrist and MTP (1-5) joints at the most painful side. Two readers scored synovitis and bone marrow oedema (BME) according to the OMERACT RA MRI scoring method and assessed tenosynovitis. The MRI data were first analysed continuously and then dichotomised to analyse the concordance with inflammation at joint examination. RESULTS 1790 joints of 179 patients were studied. Synovitis and tenosynovitis on MRI were independently associated with clinical swelling, in contrast to BME. In 86% of the swollen MCP joints and in 92% of the swollen wrist joints any inflammation on MRI was present. In 27% of the non-swollen MCP joints and in 66% of the non-swollen wrist joints any MRI inflammation was present. Vice versa, of all MCP, wrist and MTP joints with inflammation on MRI 64%, 61% and 77%, respectively, were not swollen. BME, also in case of severe lesions, occurred frequently in clinically non-swollen joints. Similar results were observed for joint tenderness. CONCLUSIONS Inflammation on MRI is not only present in clinically swollen but also in non-swollen joints. In particular BME occurred in clinically non-inflamed joints. The relevance of subclinical inflammation for the disease course is a subject for further studies.
Collapse
Affiliation(s)
- A Krabben
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
| | - W Stomp
- Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
| | - T W J Huizinga
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
| | - D van der Heijde
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
| | - J L Bloem
- Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
| | - M Reijnierse
- Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
| | | |
Collapse
|
199
|
Ramiro S, van Tubergen A, van der Heijde D, van den Bosch F, Dougados M, Landewe R. How to deal with missing items in BASDAI and BASFI. Rheumatology (Oxford) 2013; 53:374-6. [DOI: 10.1093/rheumatology/ket396] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
200
|
Moltó A, Paternotte S, Comet D, Thibout E, Rudwaleit M, Claudepierre P, van der Heijde D, Dougados M. Performances of the Assessment of SpondyloArthritis International Society axial spondyloarthritis criteria for diagnostic and classification purposes in patients visiting a rheumatologist because of chronic back pain: results from a multicenter, cross-sectional study. Arthritis Care Res (Hoboken) 2013; 65:1472-81. [PMID: 23554182 DOI: 10.1002/acr.22016] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2012] [Accepted: 03/20/2013] [Indexed: 01/11/2023]
Abstract
OBJECTIVE To evaluate the performances (sensitivity, specificity, and positive and negative predictive values) at diagnosis and study visit of the Assessment of SpondyloArthritis international Society (ASAS) criteria in axial spondyloarthritis in patients with chronic back pain (CBP). A secondary objective was to identify the most contributory item to diagnosis/classify spondyloarthritis. METHODS We conducted a multicenter, cross-sectional study. Patients were ages <45 years with a history of CBP and seeing a rheumatologist in France. Data included items from the different sets of criteria, checking if present at diagnosis ("diagnosis")/after diagnosis, but at study visit ("classification"), and the rheumatologist's diagnosis at study visit. Statistical analysis included descriptive characteristics and performances for diagnosis and classification. The diagnosis of the rheumatologist was considered the "gold standard." RESULTS A total of 1,210 patients were eligible for our analysis. Sensitivity and specificity for ASAS axial criteria were 0.76 and 0.94, respectively, and 0.87 and 0.92 for diagnostic and classification purposes, respectively. The positive likelihood ratio of the ASAS axial criteria was 13.6 and 10.30 for diagnostic and classification purposes, respectively. The most contributory items to diagnosis and classification were radiographic sacroiliitis, followed by magnetic resonance imaging sacroiliitis for diagnosis and history of uveitis for classification. CONCLUSION We confirm the validity of the ASAS criteria for both diagnostic and classification purposes in a clinical setting of patients with CBP.
Collapse
Affiliation(s)
- A Moltó
- Hôpital Cochin, René Descartes University, Paris, France; Universitat Autònoma de Barcelona, Barcelona, Spain
| | | | | | | | | | | | | | | |
Collapse
|